[HTML][HTML] Immunotherapy advances in locally advanced and recurrent/metastatic head and neck squamous cell carcinoma and its relationship with human …
H Wang, Q Zhao, Y Zhang, Q Zhang, Z Zheng… - Frontiers in …, 2021 - frontiersin.org
Head and neck cancer (HNC) is the sixth most common malignancy worldwide; head and
neck squamous cell carcinoma (HNSCC) account for the most cases of HNC. Past smoking …
neck squamous cell carcinoma (HNSCC) account for the most cases of HNC. Past smoking …
[HTML][HTML] Immunotherapy approaches in HPV-associated head and neck cancer
R Julian, M Savani, JE Bauman - Cancers, 2021 - mdpi.com
Simple Summary Human papillomavirus (HPV)-positive head and neck squamous cell
carcinoma (HNSCC) represents a distinct entity with molecular, pathological, and clinical …
carcinoma (HNSCC) represents a distinct entity with molecular, pathological, and clinical …
Immunotherapy for head and neck cancer patients: shifting the balance
AW Turksma, BJM Braakhuis, E Bloemena… - …, 2013 - Taylor & Francis
Head and neck squamous cell carcinoma is the sixth most common cancer in the western
world. Over the last few decades little improvement has been made to increase the relatively …
world. Over the last few decades little improvement has been made to increase the relatively …
Immunotherapy for Head and Neck Cancers
Q Wu - Handbook of Cancer and Immunology, 2023 - Springer
Head and neck squamous cell carcinomas (HNSCCs) are the seventh most common
malignancy worldwide. HNSCCs are highly heterogeneous diseases with varied genetic …
malignancy worldwide. HNSCCs are highly heterogeneous diseases with varied genetic …
[HTML][HTML] Novel immunotherapeutic approaches to treating HPV-related head and neck cancer
NF Saba, S Pamulapati, B Patel, M Mody, P Strojan… - Cancers, 2023 - mdpi.com
Simple Summary Recent advances in immunotherapeutic approaches have spanned
different tumor types including head and neck cancer. HPV-related head and Neck Cancers …
different tumor types including head and neck cancer. HPV-related head and Neck Cancers …
Immunotherapy of head and neck cancer: emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting
Recent advances have permitted successful therapeutic targeting of the immune system in
head and neck squamous cell carcinoma (HNSCC). These new immunotherapeutic targets …
head and neck squamous cell carcinoma (HNSCC). These new immunotherapeutic targets …
Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis
MM Galvis, GA Borges, TB de Oliveira… - Critical Reviews in …, 2020 - Elsevier
Background Despite multiple modalities used to management of head and neck squamous
cell carcinoma (HNSCC), disease control remains unsatisfactory. Immunotherapy is …
cell carcinoma (HNSCC), disease control remains unsatisfactory. Immunotherapy is …
[HTML][HTML] Immunotherapy in HPV-related oropharyngeal cancers
L Roof, E Yilmaz - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement Human papillomavirus (HPV)–related oropharyngeal squamous cell
carcinoma (OPSCC) incidence has been increasing in recent decades. Treatment of the …
carcinoma (OPSCC) incidence has been increasing in recent decades. Treatment of the …
[HTML][HTML] The tumor-specific immune landscape in HPV+ head and neck cancer
JP Conarty, A Wieland - Viruses, 2023 - mdpi.com
Human papillomaviruses (HPVs) are the causative agent of several anogenital cancers as
well as head and neck cancers, with HPV+ head and neck squamous cell carcinoma …
well as head and neck cancers, with HPV+ head and neck squamous cell carcinoma …
Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics
Head and neck squamous cell carcinoma (HNSCC) accounts for more than 600,000 cases
and 380,000 deaths annually worldwide. Although human papillomavirus (HPV)–associated …
and 380,000 deaths annually worldwide. Although human papillomavirus (HPV)–associated …